{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:57:10Z","timestamp":1792277830603,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpha.2023.11.011","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:40:29Z","timestamp":1701283229000},"page":"100904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Apatinib and gamabufotalin co-loaded lipid\/Prussian blue nanoparticles for synergistic therapy to gastric cancer with metastasis"],"prefix":"10.1016","volume":"14","author":[{"given":"Binlong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2023.11.011_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.jpha.2023.11.011_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on management of gastric cancer","volume":"21","author":"Johnston","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jpha.2023.11.011_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cam4.1274","article-title":"Medical management of gastric cancer: A 2017 update","volume":"7","author":"Charalampakis","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.jpha.2023.11.011_bib4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejso.2017.02.013","article-title":"Beyond precision surgery: Molecularly motivated precision care for gastric cancer","volume":"43","author":"Choi","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jpha.2023.11.011_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchromb.2012.03.027","article-title":"Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study","volume":"895\u2013896","author":"Ding","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpha.2023.11.011_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-529","article-title":"Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies","volume":"10","author":"Li","year":"2010","journal-title":"BMC Cancer."},{"key":"10.1016\/j.jpha.2023.11.011_bib7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1349-7006.2011.01939.x","article-title":"YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo","volume":"102","author":"Tian","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jpha.2023.11.011_bib8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14740338.2018.1535592","article-title":"The safety of apatinib for the treatment of gastric cancer","volume":"17","author":"Geng","year":"2018","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jpha.2023.11.011_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2016.01.014","article-title":"Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer","volume":"372","author":"Roviello","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpha.2023.11.011_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/dmd.112.050310","article-title":"Metabolism and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor apatinib in humans","volume":"41","author":"Ding","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2023.11.011_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jpha.2023.11.011_bib12","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.18632\/oncotarget.6514","article-title":"Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.jpha.2023.11.011_bib13","article-title":"Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+\/K+-ATPase","volume":"12","author":"Moreno","year":"2013","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.jpha.2023.11.011_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.actbio.2020.06.025","article-title":"Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition","volume":"113","author":"Fan","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jpha.2023.11.011_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108849","article-title":"Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87","volume":"314","author":"Yuan","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2023.11.011_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4251\/wjgo.v4.i7.156","article-title":"Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention","volume":"4","author":"Nagini","year":"2012","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.jpha.2023.11.011_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1634\/theoncologist.2011-0311","article-title":"Targeted therapy in the management of advanced gastric cancer: Are we making progress in the era of personalized medicine?","volume":"17","author":"Wong","year":"2012","journal-title":"Oncologist."},{"key":"10.1016\/j.jpha.2023.11.011_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202201306","article-title":"Bifunctional fusion membrane-based hydrogel enhances antitumor potency of autologous cancer vaccines by activating dendritic cells","volume":"32","author":"Ke","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jpha.2023.11.011_bib19","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/IJN.S249174","article-title":"Superior antitumor efficacy of IFN-alpha2b-incorporated photo-cross-linked hydrogels combined with T cell transfer and low-dose irradiation against gastric cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jpha.2023.11.011_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/IJN.S231448","article-title":"Antitumor activity of thermosensitive hydrogels packaging gambogic acid nanoparticles and tumor-penetrating peptide iRGD against gastric cancer","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jpha.2023.11.011_bib21","first-page":"1","article-title":"Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer","volume":"23","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jpha.2023.11.011_bib22","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1002\/adma.201503381","article-title":"A prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity","volume":"27","author":"Cai","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jpha.2023.11.011_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtadv.2022.100245","article-title":"Hybrid membrane-camouflaged hollow prussian blue nanoparticles for shikonin loading and combined chemo\/photothermal therapy of metastatic TNBC","volume":"14","author":"Liang","year":"2022","journal-title":"Materials Today Advances."},{"key":"10.1016\/j.jpha.2023.11.011_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119936","article-title":"PB@PDA@Ag nanosystem for synergistically eradicating MRSA and accelerating diabetic wound healing assisted with laser irradiation","volume":"243","author":"Tong","year":"2020","journal-title":"Biomaterials."},{"key":"10.1016\/j.jpha.2023.11.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119301","article-title":"RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo\/photothermal therapy of breast cancer","volume":"217","author":"Liu","year":"2019","journal-title":"Biomaterials."},{"key":"10.1016\/j.jpha.2023.11.011_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2021.09.034","article-title":"Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo\/photothermal therapy of cervical cancer and anti-inflammation","volume":"339","author":"Xiao","year":"2021","journal-title":"J. Contr. Release."},{"key":"10.1016\/j.jpha.2023.11.011_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.271.5245.43","article-title":"Supported membranes: scientific and practical applications","volume":"271","author":"Sackmann","year":"1996","journal-title":"Science."},{"key":"10.1016\/j.jpha.2023.11.011_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","article-title":"Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan","volume":"18","author":"Tammi","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2023.11.011_bib29","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2023.11.011_bib30","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/acsnano.5b00510","article-title":"Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice","volume":"9","author":"Meng","year":"2015","journal-title":"ACS Nano."},{"key":"10.1016\/j.jpha.2023.11.011_bib31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jconrel.2021.12.021","article-title":"Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux","volume":"341","author":"Zhou","year":"2022","journal-title":"J. Contr. Release."},{"key":"10.1016\/j.jpha.2023.11.011_bib32","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1039\/D1TB00029B","article-title":"A hybrid membrane coating nanodrug system against gastric cancer via the VEGFR2\/STAT3 signaling pathway","volume":"9","author":"Long","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jpha.2023.11.011_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111219","article-title":"Biomimetic hybrid-cell membrane nanoparticles loaded with panaxytriol for breast cancer combinational therapy","volume":"223","author":"Xie","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.jpha.2023.11.011_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/1061186X.2022.2162060","article-title":"Biomimetic graphene oxide quantum dots nanoparticles targeted photothermal-chemotherapy for gastric cancer","volume":"31","author":"Lei","year":"2023","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jpha.2023.11.011_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtadv.2022.100289","article-title":"Biomimetic PLGA-based nanocomplexes for improved tumor penetration to enhance chemo-photodynamic therapy against metastasis of TNBC","volume":"16","author":"Fan","year":"2022","journal-title":"Materials Today Advances."},{"key":"10.1016\/j.jpha.2023.11.011_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrm2820","article-title":"Sensors and regulators of intracellular pH","volume":"11","author":"Casey","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpha.2023.11.011_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900795","article-title":"Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jpha.2023.11.011_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2023.11.011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173379","article-title":"Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment","volume":"887","author":"Deng","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpha.2023.11.011_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<186::AID-PATH418>3.0.CO;2-L","article-title":"Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1\/CIP1 in gastric cancer","volume":"189","author":"M\u00fcller","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.jpha.2023.11.011_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpha.2023.11.011_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-203","article-title":"Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK\u03b2\/NF-\u03baB signaling pathway in lung cancer cells","volume":"13","author":"Yu","year":"2014","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.jpha.2023.11.011_bib43","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acs.molpharmaceut.5b00952","article-title":"Repeated administration of hyaluronic acid coated liposomes with improved pharmacokinetics and reduced immune response","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpha.2023.11.011_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2011","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.jpha.2023.11.011_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.jpha.2023.11.011_bib46","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.biomaterials.2014.02.024","article-title":"The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.jpha.2023.11.011_bib47","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","article-title":"Safety of nanoparticles in medicine","volume":"16","author":"Wolfram","year":"2015","journal-title":"Curr. Drug Targets."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923002757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923002757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T11:38:17Z","timestamp":1717328297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177923002757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2095177923002757"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2023.11.011","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apatinib and gamabufotalin co-loaded lipid\/Prussian blue nanoparticles for synergistic therapy to gastric cancer with metastasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2023.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"100904"}}